Results 181 to 190 of about 3,139,763 (202)
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Aims The Black Triangle Scheme, introduced in 2018 in Australia, does not appear to have increased the quantity of adverse drug event (ADE) reports. This study evaluated healthcare professionals' (HCPs') and consumers' awareness of the scheme, its influence on intentions for future ADE reporting, and suggested improvements.
Eyob Alemayehu Gebreyohannes +7 more
wiley +1 more source
Medicines, misinformation and machines: Navigating infodemics in the generative AI era
Health information is now widely accessed through smartphones, online searches and increasingly through generative artificial intelligence (AI). These systems create new opportunities for communication, and in some routine contexts, well‐governed AI assistants could reduce exposure to lower quality sources by providing cautious, evidence‐aligned ...
Natansh D. Modi +3 more
wiley +1 more source
Economic evaluations of antiobesity medications: A systematic literature review
The global prevalence of obesity is rising rapidly. With several antiobesity medications approved and many more in development, understanding their economic value is increasingly important. This study reviews full economic evaluations of approved antiobesity medications to assess cost‐effectiveness and inform reimbursement and access decisions.
Martina Jurković +5 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.
Shawnalyn W. Sunagawa +11 more
wiley +1 more source
Earning Management: The Effect of Financial Stability, External Monitoring Mechanism, Opportunistic Behavior, and Ineffective Monitoring [PDF]
This study aims to determine the effect of financial stability as measured by changes in assets (ACHANGE), external monitoring mechanism (DAR) and opportunistic behavior (FCF) on earnings management. The addition of the ineffective monitoring variable as
Emrinaldi Nur Dp
exaly +2 more sources
The purpose of this research is to find out the impact of financial financial monitoring, ineffective monitoring and financial distress on fraudulent financial statements directed at companies in industries the property, real estate and construction ...
Yuha Nadhirah Qintharah
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Active Monitoring of DCIS Shows Promise in Short-Term Study
Ca-A Cancer Journal for CliniciansCarrie Printz
exaly

